Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 3669986
Author(s) Jukić, M. M.; Opel, N.; Ström, J.; Carrillo-Roa, T.; Miksys, S.; Novalen, M.; Renblom, A.; Sim, S. C.; Peñas-Lledó, E. M.; Courtet, P.; Llerena, A.; Baune, B. T.; de Quervain, D. J.; Papassotiropoulos, A.; Tyndale, R. F.; Binder, E. B.; Dannlowski, U.; Ingelman-Sundberg, M.
Author(s) at UniBasel de Quervain, Dominique
Papassotiropoulos, Andreas
Year 2017
Title Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment
Journal Molecular Psychiatry
Volume 22
Number 8
Pages / Article-Number 1155-1163
Mesh terms African Americans, genetics; Animals; Anxiety, genetics; Anxiety Disorders, genetics; Behavior, Animal, drug effects; Brain-Derived Neurotrophic Factor, metabolism; Citalopram, pharmacology; Cytochrome P-450 CYP2C19, metabolism; Depression, genetics; Depressive Disorder, Major, metabolism; Hippocampus, metabolism; Homeostasis, physiology; Humans; Mice; Mice, Transgenic; Neurogenesis, genetics; Receptor, Serotonin, 5-HT1A, metabolism; Serotonin, metabolism; Serotonin 5-HT1 Receptor Agonists, pharmacology
Abstract The polymorphic CYP2C19 enzyme metabolizes psychoactive compounds and is expressed in the adult liver and fetal brain. Previously, we demonstrated that the absence of CYP2C19 is associated with lower levels of depressive symptoms in 1472 Swedes. Conversely, transgenic mice carrying the human CYP2C19 gene (2C19TG) have shown an anxious phenotype and decrease in hippocampal volume and adult neurogenesis. The aims of this study were to: (1) examine whether the 2C19TG findings could be translated to humans, (2) evaluate the usefulness of the 2C19TG strain as a tool for preclinical screening of new antidepressants and (3) provide an insight into the molecular underpinnings of the 2C19TG phenotype. In humans, we found that the absence of CYP2C19 was associated with a bilateral hippocampal volume increase in two independent healthy cohorts (N=386 and 1032) and a lower prevalence of major depressive disorder and depression severity in African-Americans (N=3848). Moreover, genetically determined high CYP2C19 enzymatic capacity was associated with higher suicidality in depressed suicide attempters (N=209). 2C19TG mice showed high stress sensitivity, impaired hippocampal Bdnf homeostasis in stress, and more despair-like behavior in the forced swim test (FST). After the treatment with citalopram and 5-HT1A receptor agonist 8OH-DPAT, the reduction in immobility time in the FST was more pronounced in 2C19TG mice compared with WTs. Conversely, in the 2C19TG hippocampus, metabolic turnover of serotonin was reduced, whereas ERK1/2 and GSK3β phosphorylation was increased. Altogether, this study indicates that elevated CYP2C19 expression is associated with depressive symptoms, reduced hippocampal volume and impairment of hippocampal serotonin and BDNF homeostasis.Molecular Psychiatry advance online publication, 29 November 2016; doi:10.1038/mp.2016.204.
Publisher Nature Publishing Group
ISSN/ISBN 1359-4184 ; 1476-5578
URL https://www.nature.com/articles/mp2016204.pdf
edoc-URL http://edoc.unibas.ch/45094/
Full Text on edoc No
Digital Object Identifier DOI 10.1038/mp.2016.204
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/27895323
ISI-Number WOS:000406046400011
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.330 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
12/05/2024